Associations Between Change in BMI and the Risk of Hypertension and Dyslipidaemia in People Receiving Integrase Strand-Transfer Inhibitors, Tenofovir Alafenamide, or Both Compared with Other Contemporary Antiretroviral Regimens: a Multicentre, Prospective Observational Study from the RESPOND Consortium Cohorts